Abstract
BackgroundPatients with head and neck cancer (HNC) who are receiving radiotherapy commonly face detrimental complications, including oral issues. However, oral symptoms are not well understood given the lack of available specific assessment instruments. The Vanderbilt Head and Neck Symptom Survey version (VHNSS) 2.0 is an instrument specifically developed to identify oral symptoms in HNC patients receiving radiotherapy in the United States.ObjectiveTo perform the translation and cross-cultural adaptation of the original English version of VHNSS 2.0 into a Chinese version (Mainland China).MethodsThe translation and cultural adaptation process involved translation by independent translators, construction of a consensus version, back translation into the original English version, analysis by the expert committee and a pretest. The pretest was administered to 90 patients with HNC to assess the feasibility and practicality of the tool.ResultsThe final Chinese version approved by the expert committee was well understood by all participants in the study. The instrument had satisfactory content validity, with indexes of 0.83 for semantic and idiomatic equivalence, 0.90 for cultural equivalence, and 0.91 for conceptual equivalence. Furthermore, this version had good internal consistency, with Cronbach's alpha coefficients ranging from 0.74 to 0.95.ConclusionThe Chinese version of VHNSS 2.0 was translated and cross-culturally adapted for use in China. This translation is a feasible instrument to assess oral health-related quality of life in HNC patients undergoing radiotherapy and will be useful for symptom management by clinicians and researchers in China.
Highlights
Head and neck cancer (HNC), a heterogeneous group of upper aerodigestive tract malignancies, is the sixth most common cancer worldwide [1]
The final Chinese version approved by the expert committee was well understood by all participants in the study
In the step of forward-translation, the two forward translators independently translated the original version of Vanderbilt Head and Neck Symptom Survey (VHNSS) 2.0 into Chinese (V1 and V2 forward translation)
Summary
Head and neck cancer (HNC), a heterogeneous group of upper aerodigestive tract malignancies, is the sixth most common cancer worldwide [1]. The standard treatment for patients with HNC is surgery, radiotherapy (RT), chemotherapy, targeted therapy or a combination of these treatments [3, 4]. A large proportion of patients with HNC survive after treatment, but some of the treatment sequelae influence the survivors’ QOL for a long time. Clinical administrators collaborate in a multidisciplinary team to develop cancer management plans and address treatment related side effects to improve survivors’ QOL. Patients with head and neck cancer (HNC) who are receiving radiotherapy commonly face detrimental complications, including oral issues. The Vanderbilt Head and Neck Symptom Survey version (VHNSS) 2.0 is an instrument developed to identify oral symptoms in HNC patients receiving radiotherapy in the United States
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
